Literature DB >> 20824286

Modulation of B cell responses by Toll-like receptors.

Jayaum Booth1, Heather Wilson, Steve Jimbo, George Mutwiri.   

Abstract

B lymphocytes are well known because of their key role in mediating humoral immune responses. Upon encounter with antigen and on cognate interaction with T cells, they differentiate into antibody-secreting plasma cells, which are critical for protection against a variety of pathogens. In addition to their antibody-production function, B cells are efficient antigen-presenting cells and express a variety of pathogen recognition receptors (PRRs). Engagement of these PRRs with their respective ligands results in cytokine and chemokine secretion and the upregulation of co-stimulatory molecules. These events constitute innate immune responses. Toll-like receptor (TLR) activation provides a third signal for B cell activation and is essential for optimal antigen-specific antibody responses. In some situations, TLR activation in B cells can result in autoimmunity. The purpose of this review is to provide some insights into the way that TLRs influence innate and adaptive B cell responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824286     DOI: 10.1007/s00441-010-1031-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  23 in total

1.  Syk is indispensable for CpG-induced activation and differentiation of human B cells.

Authors:  Mariann Kremlitzka; Bernadett Mácsik-Valent; Anna Erdei
Journal:  Cell Mol Life Sci       Date:  2014-12-28       Impact factor: 9.261

2.  Beyond transitional selection: New roles for BLyS in peripheral tolerance.

Authors:  Michael A Oropallo; Kerstin Kiefer; Ann Marshak-Rothstein; Michael P Cancro
Journal:  Drug Dev Res       Date:  2011-12       Impact factor: 4.360

3.  The atypical IκB protein IκB(NS) is important for Toll-like receptor-induced interleukin-10 production in B cells.

Authors:  Minami Miura; Naoki Hasegawa; Mitsuo Noguchi; Kenkichi Sugimoto; Maki Touma
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

4.  Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR).

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; Dewitt M Jones; Brian Dizon; Zilu Zhu; Hiroshi Ohno; Shozo Izui; John F Kearney; Hiromi Kubagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 5.  Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.

Authors:  Akbar Mohammad Hosseini; Jafar Majidi; Behzad Baradaran; Mehdi Yousefi
Journal:  Adv Pharm Bull       Date:  2015-12-31

Review 6.  Toll-like receptor function in primary B cell defects.

Authors:  Thomas U Marron; Joyce E Yu; Charlotte Cunningham-Rundles
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

7.  Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.

Authors:  Jianwu Pei; Xicheng Ding; Yaping Fan; Allison Rice-Ficht; Thomas A Ficht
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

8.  Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.

Authors:  Lucja A Labuda; Ulysse Ateba-Ngoa; Eliane Ngoune Feugap; Jorn J Heeringa; Luciën E P M van der Vlugt; Regina B A Pires; Ludovic Mewono; Peter G Kremsner; Menno C van Zelm; Ayola A Adegnika; Maria Yazdanbakhsh; Hermelijn H Smits
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07

9.  Adsorption of Toll-Like Receptor 4 Agonist to Alum-Based Tetanus Toxoid Vaccine Dampens Pro-T Helper 2 Activities and Enhances Antibody Responses.

Authors:  Juliana Bortolatto; Luciana Mirotti; Dunia Rodriguez; Eliane Gomes; Momtchilo Russo
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

10.  Transcriptional heterogeneity of IgM+ cells in rainbow trout (Oncorhynchus mykiss) tissues.

Authors:  Beatriz Abós; Rosario Castro; Jaime Pignatelli; Alfonso Luque; Lucia González; Carolina Tafalla
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.